Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13615783 | 0.80 | HDAC6 (0.44) | BCHEHDAC6ACHEMAOAMEN1 | |
| SCHEMBL13615968 | 0.80 | HDAC6 (0.44) | BCHEHDAC6ACHEMAOAMEN1 | |
| SCHEMBL22260214 | 0.80 | BCHE (0.34) | BCHEHDAC6ACHETDP1 | |
| SCHEMBL13508168 | 0.79 | HDAC6 (0.40) | BCHEHDAC6ACHEMAOAMEN1 | |
| SCHEMBL22260322 | 0.78 | TDP1 (0.34) | TDP1 | |
| SCHEMBL13507046 | 0.78 | HDAC6 (0.40) | BCHEHDAC6ACHEMAOAMEN1 | |
| SCHEMBL17915741 | 0.75 | HDAC6 (0.47) | BCHEHDAC6ACHEMAOAMEN1 | |
| SCHEMBL17915737 | 0.75 | HDAC6 (0.47) | BCHEHDAC6ACHEMAOAMEN1 | |
| SCHEMBL21888305 | 0.74 | BCHE (0.33) | BCHEHDAC6ACHE | |
| SCHEMBL22260512 | 0.74 | CYP1A1 (0.33) | ACHETDP1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235315-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235315-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | TRPA1, PIEZO1, SLCO4C1 | BCHE 1525/4885HDAC6 4451/4885ACHE 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.